MedImmune Synagis (correction)
Executive Summary
Reconstitution of MedImmune's Synagis (palivizumab) should be done with sterile water, not saline (1"The Pink Sheet" Oct. 15, p. 24)
You may also be interested in...
Synagis Re-Treatment Patients Represent 21% Of Use, MedImmune Says
Re-treatment with Synagis made up approximately 21% of MedImmune's sales of the monoclonal antibody product during last year's respiratory syncytial virus season.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials